Sri Lanka vs East Timor: Prevalence rate of hypertension in women aged 30-79
Sri Lanka
36.5
in 2019
East Timor
36.7
in 2019
Sri Lanka rank
111th
East Timor rank
110th
Prevalence rate of hypertension in women aged 30-79 over time
- Sri Lanka
- East Timor
How they compare
East Timor currently reports 36.7 against 36.5 in Sri Lanka, a difference of 0.2.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Sri Lanka ahead.
Sri Lanka ranks 111th and East Timor ranks 110th of 195 countries.
Across the 3 decades both report, Sri Lanka averaged higher in 1 and East Timor in 1.
Head to head by decade
| Decade | Sri Lanka | East Timor | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 32.09 | 29.71 | 2.38 | Sri Lanka |
| 2000s | 32.33 | 32.33 | 0 | — |
| 2010s | 35 | 35.39 | 0.39 | East Timor |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in women aged 30-79, Sri Lanka or East Timor?
- East Timor, at 36.7 against 36.5 in Sri Lanka as of 2019.
- What is the difference in prevalence rate of hypertension in women aged 30-79 between Sri Lanka and East Timor?
- 0.2, with East Timor ahead.
- How many years of comparable data are there for Sri Lanka and East Timor?
- 30 years are reported by both, from 1990 to 2019.
- How do Sri Lanka and East Timor rank globally for prevalence rate of hypertension in women aged 30-79?
- Sri Lanka ranks 111th and East Timor ranks 110th of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in women aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of female population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.